Branaplam Uses, Dosage, Side Effects and more
Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).
| Attribute | Details |
|---|---|
| Trade Name | Branaplam |
| Generic | Branaplam |
| Branaplam Other Names | Branaplam |
| Type | |
| Formula | C22H27N5O2 |
| Weight | Average: 393.491 Monoisotopic: 393.216475129 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
